Archives
-
Cobalt Single-Atom Switches for Multimodal Phototherapy
2026-09-18
This Nature Communications study develops a near-infrared-triggered cobalt single-atom enzyme on hollow N-doped carbon spheres for integrated photodynamic, photocatalytic, and photothermal therapy. Its central contribution is a mechanistic design in which photogenerated electrons and photothermal conversion amplify reactive oxygen species while mild hyperthermia and ROS-associated apoptosis and ferroptosis reinforce tumor damage.
-
Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-09-18
The Annexin V-Cy5/DAPI Apoptosis Kit converts phosphatidylserine exposure and membrane integrity into a rapid two-parameter cell-death profile. This guide connects practical flow-cytometry and microscopy workflows with the P2RX1–CaMKII–PI3K/Akt apoptosis mechanism reported in Philadelphia chromosome-positive acute lymphoblastic leukemia.
-
Caspase-8 in Hyperthermia-Cisplatin Therapy
2026-09-17
This study identifies a caspase-8-centered mechanism by which hyperthermia enhances cisplatin-induced cancer cell death. The work connects CUL3-dependent K63-linked polyubiquitination, p62 interaction, apoptosis, and gasdermin-associated pyroptosis, providing a mechanistic basis for combining thermal treatment with chemotherapy.
-
Sulfamonomethoxine Toxicity Across Aquatic Species
2026-09-17
Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka, combining acute and chronic bioassays to compare sensitivity across aquatic taxa. The study identifies microalgae as the most sensitive tested group and provides a useful framework for interpreting veterinary antibiotic residues in aquaculture-related waters.
-
Sodium chloride B7288: Buffer QC Guide
2026-09-16
Sodium chloride B7288 is an inorganic salt for setting ionic strength and supporting osmotic balance in aqueous buffers, biochemical assays, and cell culture media workflows. Use it as a water-based laboratory reagent, not as a pH buffer, DMSO or ethanol stock, or replacement for sterility-qualified material.
-
Clozapine N-oxide for Circuit Chemogenetics
2026-09-16
Clozapine N-oxide (CNO) enables reversible DREADD-based control of defined neural pathways, making it especially useful for separating circuit causality from correlation. This workflow translates the sTRN–LHb depression study into practical choices for neuronal activity modulation, behavioral testing, and GPCR signaling research.
-
Sodium chloride B7288: Buffer QC Guide
2026-09-15
Sodium chloride B7288 provides a defined source of ionic strength for aqueous buffer preparation, biochemical assays, and cell culture media workflows. It should be dissolved in water and used promptly; it is not a pH buffer, a DMSO- or ethanol-compatible reagent, or a substitute for sterility-qualified material.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-15
Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than a wild-type background. The system confirmed activity for established TOR inhibitors and aminophylline, while finding no evidence that Canagliflozin inhibited TOR in this yeast growth assay, helping define a mechanistic boundary for follow-up studies.
-
Darunavir Ethanolate Research Workflow
2026-09-14
Darunavir Ethanolate (SKU B4950) provides a defined research compound for HIV protease inhibition, transporter studies, and HIV drug resistance experiments. It is intended for controlled scientific workflows only, not for diagnosis, treatment decisions, or direct clinical use.
-
BMX-IN-1: Selective BMX Kinase Inhibitor
2026-09-14
BMX-IN-1 is an irreversible BMX kinase inhibitor for mechanistic studies of Tec-family signaling, cancer biology, angiogenesis, and host–pathogen interactions. Product information describes selective BMX inhibition, G0/G1 cell-cycle arrest, apoptosis induction, and activity at 300 nM after 24 hours in cellular assays.
-
MG-132: Proteostasis Control in Immune Assays
2026-09-13
MG-132 (Z-LLL-al) provides a controlled way to interrogate proteostasis, apoptosis, and antigen-response assays. This article connects its mechanism to immune-study design without overstating evidence from a recent monkeypox mRNA vaccine study.
-
3-Bromopyruvate Reverses Cetuximab Resistance
2026-09-12
The reference study shows that 3-bromopyruvate combined with cetuximab can suppress intrinsically or acquired cetuximab-resistant colorectal cancer cells through coordinated ferroptosis, autophagy, and apoptosis. Its central mechanistic contribution is linking FOXO3a restoration to AMPKα/pBeclin1 and PUMA signaling, providing a framework for studying resistance-directed combination therapy.
-
Ziprasidone–GOT1 Reprogramming in Pancreatic Cancer
2026-09-11
A 2022 Journal of Molecular Medicine study identified ziprasidone as a noncompetitive inhibitor of GOT1, linking enzyme inhibition to disrupted glutamine metabolism, redox imbalance, and reduced pancreatic ductal adenocarcinoma growth. Its combination of enzyme kinetics, cellular assays, metabolomics, genetic perturbation, and xenograft validation provides a useful framework for studying GOT1 as a metabolic vulnerability while leaving questions about selectivity and clinical translation.
-
SLC2A5 Fructose Metabolism in Primary CNS Lymphoma
2026-09-11
This 2026 Advanced Science study uses single-cell RNA and B-cell receptor profiling to connect the metabolically restricted primary CNS lymphoma microenvironment with SLC2A5-mediated fructose utilization. Functional experiments identify SLC2A5 as a potential vulnerability in lymphoma cells and tumor-supportive macrophages, while offering a rationale for spatial and tissue-level validation.
-
Cdk5, AMPK, and Ferroptosis After Ischemic Stroke
2026-09-10
This study links Cdk5 inhibition to reduced hippocampal neuronal ferroptosis through AMPK signaling and suppression of proinflammatory microglial activation after ischemic stroke. Its combined animal and cell-model design supports a mechanistic framework for studying how kinase signaling, neuroinflammation, and iron-dependent cell death interact.